Scenic Biotech adds Dr. Stephan Christgau, Dr. Michael Wacker and Stephane Verdood to Board along with raising €28 Series A financing

– NETHERLANDS, Amsterdam –  Scenic Biotech BV, a pioneer in the discovery of genetic modifiers today announced it has closed a €28 million Series A financing round co-led by Eir Ventures, BioMedPartners, and Vesalius Biocapital alongside existing investors Inkef Capital, BioGeneration Ventures, and Oxford Science Enterprises also participating.…

TargED Biopharma strengthens its Board of Directors along with raising €39m Series A financing

– NETHERLANDS, Utrecht –  TargED Biopharmaceuticals, a private biotechnology company focused on developing improved treatments for thrombotic diseases, today announced it has raised Series A financing of EUR 39 million led by an international syndicate comprising Andera Partners, Fund+, Hadean Ventures, Inkef Capital, and Sunstone Life Science Ventures, and joined by existing investors FIRST, Curie Capital and Utrecht Health Seed Fund.…